Skip to main content
Caplight Logo









Yiviva

Yiviva

Private
New York City, New YorkHealthcare & Life Scienceshttps://yiviva.com/

Last Round

Series A

Feb 21, 2018

Total Funding Raised

$7M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Yiviva is a biotechnology company that develops multi-target therapeutics from botanical medicines to treat complex, aging-associated diseases, with a focus on cancer and inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

botanical medicinemulti-target therapeuticstraditional Chinese medicineherbal medicinecancer therapysystems biologyTCMcombination therapyimmunotherapy enhancementclinical stage biotechdrug discovery platformdrug licensingOrphan Drug Designationinflammatory bowel diseaseIBDliver cancer

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Yiviva Comparables

Compare Yiviva with similar companies based on industry and business-model similarity.

Yiviva comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
HUTCHMED (China) Limited
78%
Tvardi
71%
Can Fite Biopharma Ltd ADR
64%

Yiviva Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AFeb 21, 2018

Yiviva Investors

Notable investors and investment history

Yiviva investors
InvestorRounds
Asian Fund for Cancer ResearchSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 82% MoM, reaching 5.7K.

  • Mar 3, 2026

    Monthly visitors increased 44% MoM.

Yiviva Filings

Explore SEC and related filing metadata, where available.

Yiviva filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Yiviva's valuation, stock price, and market status.

Is Yiviva a public or private company?

Yiviva is a private company.

What is the current stock price of Yiviva?

Yiviva is a private company with no public stock price. No recent secondary market data is available.

How much is Yiviva worth (valuation)?

Valuation information for Yiviva is not publicly available.

Can I buy Yiviva stock?

Yiviva shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Yiviva's last funding round?

Funding round information for Yiviva is not publicly available.

Who are the main investors in Yiviva?

Investor information for Yiviva is not publicly disclosed.

Will Yiviva IPO soon?

No public IPO plans have been announced for Yiviva.

How can I track Yiviva secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Yiviva's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range6
Year Founded2014
Last FundingFeb 21, 2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?